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Abstract
Women with increased mammographic density (MD) have an increased risk of
developing breast cancer.  The  purpose of our  study is to evaluate an experimental  method to quantify  MD using a program
(compatible with Windows XP, Vista and 7) which measures black areas as 0, white areas as 100 and grey scale areas with
intermediate values between 0 and 100, depending on the “density” of the area.  Digital screening mammograms were directly
estimated with this method. Initial idea and steps of the
program were based on a Mac utility used by our research team.
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Introduction
Digital mammography has been shown to have
at  least  equivalent  diagnostic  accuracy  to  screen-film
mammography and it offers some potential advantages
over  conventional  technology  [1]  as  magnification,
subtraction  of  parasite  signals,  contrast  and  brightness
changing, reproductivity and storage. In addition, digital
mammography can be used for subjective measurement
of breast density, which is a risk factor for future breast
cancer. Studies reported in the literature indicate that the
increase  in  the  breast  density  is  one  of  the  strongest
indicators of developing breast cancer [2, 3, 4]. Actually,
women  with  high  breast  density  are  at  higher  risk  of
breast cancer and have larger screen-detected and
interval  cancers  in  mammographic  screening
programmes [5].
A set of fibroglandular density descriptors may
be used within the text of a
mammogram  report,  roughly  corresponding  to
mammographic percent density (MPD)  as: almost entirely
fat,  scattered  fibroglandular  densities,  heterogeneously
dense and extremely dense, corresponding  to  25%,
26-50%,  51-75%  and  76%  MPD  respectively  [6].
Women with mammographic percent density (MPD) >50%
have  an  approximately three-fold  increased  risk  of
developing breast cancer [7]. Similarly, the incidence of
breast cancer among women with almost entirely dense
breasts is three to sixfold greater than that of women with
almost entirely fatty breasts, a relative risk approaching
that  conferred  by  a  diagnosis  of  atypical  ductal
hyperplasia [8, 9, 10].
However, although breast density is a strong risk
factor for breast cancer, no standard
assessment  method  of  MPD  exists  and  some
investigators  presented  their  own  method  of  density
estimation [2, 11, 12].
The  purpose  of  this  work  is  to  evaluate  an
experimental method to quantify MPD using a program
(compatible with Windows XP, Vista and 7) specifically
designed to calculate degrees of gray in mammographies.
Material and Methods
We realized a prospective study about a method
of calculation of breast mammography density. Our main
purpose  was  to  obtain  an  objective  value  of
mammographic density for digital mammography and to
“avoid” the subjectivity of estimation.
A  special  software  (compatible  with  Windows
XP, Vista and 7), which can
quantify  MD,  was  used  the  estimate  breast
density  in  digital  mammographies.  Initial  version  of  the
program was not compatible with Windows XP (Figure 1),
a problem solved in more recent versions. The programJournal of Medicine and Life Vol. 4, Issue 3, July-September 2011
© 2011, Carol Davila University Foundation
“ignores”  absolutely  black  areas.  In  absolutely  white
areas, program estimation corresponds to one hundred.
In grey scale areas the
estimated  values  are  between  0  and  100,
depending on the «density» of the area.
Moreover,  the  program  has  the  capacity  to
“surround” the breast on the mammogram and actually to
measure breast density in this particular area (Figure 2).
Initial idea,
modifications and improvements of the program
were suggested  by the first  author to the  programmer.
Further  improvements  related  to    microcalcifications
estimation and
“specialization”  of  the  program  to  recognize
digital or digitized mammograms only were suggested by
the  second  and  first  author  respectively.  For  reliable
measures, only mammograms with good “contrast” can
be used (Figure 3). Poοr quality of the mammogram can
result  in  overestimation  (Figure  4)  or  subestimation  of
breast density.
Digital screening mammograms from 39 patients
were directly estimated with the program and compared
with clinical impression, blindly estimated by the authors.
Results
Density  values  in  mediolateraloblique
mammograms  were  increased  in  comparison  with
Fig. 1.Initial incompatibility of the program with Windows XP.
Fig. 2. “Surrounding” the breast on the mammogram and
measuring breast density in this particular area
(compatibility with Windows Vista and Mac [Parallel]).
Fig.  3. For  reliable  estimation  of  breast  density  only
mammograms with good contrast must be used.
Fig.  4. Poοr  quality  of  the  mammogram  can  result  in
overestimation of breast density.Journal of Medicine and Life Vol. 4, Issue 3, July-September 2011
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craniocaudal  projections,  due  to  the  major  pectoralis
muscle  (MPM).  Therefore,  to  avoid  the  “whiteness”  of
MPM,  a  special  “intrument”  of  the  software  was  used
which  removes  the  MPM,  which  is  replaced  by  an
absolutely black area (ΑΒΑ). Taking into account that the
program ignores ABA, this area is not calculated anymore
in  the  final  estimation  of  breast  density.  Similarly,  the
black background  of mammograms  (circumferentially  of
the  breast) did  not  lower  the  real  density  value  in
mammograms,  because  as  already  mentioned,  ABΑ  is
not calculated in the final estimation. In cases of “grey”
background,  mammograms’  contrast  changed  until  to
achieve an ABΑ background. Hence, only mammograms
with  correct contrast  included  in  the  final  results.  This
method assured the correct density comparison among
mammograms because the same scale of contrast was
used to all mammograms and the breast itself had the
correct  mammographic  “density”.  Equally,  with  this
method,  no  further  calculations  were  necessary  to
compare breast
densities  among  mammograms  or  the  use  of  special
tables, and the “automated” percentages corresponded to
the real mammographic density of a particular breast.
In  relation  to  clinical  impression, we  found  a
significant  correlation  between  ACR  quartiles,  clinically
estimated,  with  this  grey  scale  percentage  method.
However, a
significant percentage of clinical estimations (18%) could
be classified as “not accurate” with a discrepancy more
than 20% of the “exact” percentage of breast density. In
particular,  7  mammogram  densities  were  over- or
subestimated (> 20 to 27% or > -20 to -25%).
Discussion
Mammographic  screening  usually  involves  the
performance of the
mediolateraloblique  and  craniocaudal projections.  In  a
previous  publication  of  our  research  team,  due  to  the
square shape of the aperture area examined with a Mac
utility, MPM was not possible to be avoided without lose a
part  of  breast  tissue  in  mediolateraloblique  projections.
On the contrary, with this specially constructed program,
the  MPM  was  removed  in  all  mediolateraloblique
mammograms  and  this  area  was  not  calculated  in  the
final estimation of breast density.
Subjective  fibroglandular  density  description
could be a useful tool of breast cancer risk estimation in a
particular  woman.  However,  some  degree  of  hesitation
could arise when such a description belongs to MPD with
increased  risk  of  breast  cancer.    On  the  contrary,  our
method has “descriptive accuracy”. The method could be
proposed  as  an  objective  tool  of  breast  density
measurement, a comparative tool between mammograms
of  the  same  woman  in  different  periods  with  different
stimulating  factors  of  mammary  proliferation  and  as
comparative  tool  among  mammograms  of  different
women,  subgrouping  them  in  age  groups,  treatment
groups etc. Similarly, previous studies, using a variety of
methods, quantified objectively the MPD, correlate it with
breast  cancer  risk  and  made  digitized  assessments  of
mammographic  breast  density  in  patients  receiving
hormonal regimens [13, 14, 15]. However, some of them
is  more  difficult  to  understand  and/or  more  time
cossuming.
Taking into account that breast density is actively
related  to  breast  cancer  risk,  methods  of  breast
densitometry  must  be  accurate, reliable,  easy  to  learn,
easy  to  perform,  widely  available,  quick,  cheap  and
repeatable.
We  believe  that  this  method  consists  an
essential improvement of our previous one regarding to
accuracy  and  estimation  of  breast  density in the  exact
“shape” of a particular breast.
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